WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Hard Copy (Hard Back) Information Icon
Live Chat Live Help Software for Website

Cardiogenic Shock. American Heart Association Clinical Series

John Wiley and Sons Ltd, July 2009, Pages: 288

- A comprehensive source of information on the management of cardiogenic shock
- Part of the AHA Clinical Series published in conjunction with the American Heart Association
- Focuses on high-interest and emerging topics in cardiovascular disease targeted to cardiologists and other interested healthcare providers
- A useful tool for investigating, evaluating and treating one of the most important lingering challenges in acute cardiovascular care

1. Risk Factors, diagnosis and epidemiology.

2. Pathophysiology (iatrogenic shock, peripheral circulation).

3. General Management.

a. Inotropes / Vasopressors.

b. Mechanical Ventilators.

c. Other Medications.

4. Pump failure - Left Ventricular.

5. Pathophysiology and management of right heart ischemia.

6. Ventricular septal rupture and tamponade.

7. Mitral regurgitation and valvular disease.

8. Cardiogenic shock in other heart diseases: acute decompensation of chronic heart failure, myocarditis, transient apical ballooning syndrome, peripartum cardiomyopathy, hypertrophic cardiomyopathy, and chronic valvular stenosis.

9. Circulatory support devices.

10. PCI (including post CABG).

11. CABG

Judith S. Hochman, MD. Clinical Chief of Cardiology. Director, Cardiovascular Clinical Research. Harold Snyder Family Professor of Cardiology. New York University School of Medicine, NY, USA. . Erik Magnus Ohman, M.D., F.A.C.C. . Professor of Medicine; Director, Program for Advanced Coronary Disease. Director, UNC Heart Center, Duke University Medical Center, Durham, NC, USA

Customers who bought this item also bought